Access to data

This study utilizes pre-diagnostic samples from the Janus Serum Bank, detailed information about the cancer diagnosis from the Cancer Registry of Norway, and epidemiological data from the National Health Survey. This provides a unique opportunity to find early biomarkers for cancer.
Last updated:
How to get access to data

All research projects that includes information and/or biological material from Janus Serum Bank must comply with the EU’s General Data Protection Regulation (GDPR). This means that the processing must have approval from the Regional Committee for Medical Research in Norway (REC). Furthermore the processing needs legal basis according to GDPR Article 6 and 9. The applicant must have considered the need for a Data Protection Impact Assessment (DPIA) according to GDPR article 35. The applicant must prove that these requirements have been met before the data can be made available. Disclosure of information and/or biological material to countries outside the EU requires that the conditions in GDPR are met. For more information email miRJanus@kreftregisteret.no.

To apply for access to published data from the JanusRNA study the applicant must fill out this form: Data access application form